Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study

Código QR

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study

Xiaoning Wang,1 Amit Roy,2 Andreas Hochhaus,3 Hagop M Kantarjian,4 Tai-Tsang Chen,5 Neil P Shah6 1Discovery Medicine and Clinical Pharmacology, Bristol-Myers Squibb, Lawrenceville, NJ, USA; 2Clinical Pharmacology and Pharmacometrics, Research and Development, Bristol-Myers Squibb, Lawrenceville, NJ,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wang X, Roy A, Hochhaus A, Kantarjian HM, Chen TT, Shah NP
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/dd2f90b8c8f34ef1bf5ded8418898035
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

First-line therapy of chronic myeloid leukemia &ndash; focus on dasatinib
por: Amrein PC
Publicado: (2012)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
por: Shoumariyeh K, et al.
Publicado: (2014)

Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines
por: Tumbocon JA, et al.
Publicado: (2019)

Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report
por: Zakaria Maat, et al.
Publicado: (2021)

Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity
por: Rhodora C. Calizo, et al.
Publicado: (2019)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Radhakrishnan Ramchandren, et al.
Publicado: (2009)

Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
por: Shoughy SS, et al.
Publicado: (2016)

Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders
por: Nikita B. Perepech, et al.
Publicado: (2021)

Canagliflozin review – safety and efficacy profile in patients with T2DM
por: Jakher H, et al.
Publicado: (2019)

Tiagabine: efficacy and safety in partial seizures &ndash; current status
por: J&uuml;rgen Bauer, et al.
Publicado: (2008)

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study
por: Chun-Hua Zhou, et al.
Publicado: (2021)

Managing blood pressure control in Asian patients: safety and efficacy of losartan
por: Cheung TT, et al.
Publicado: (2014)

Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Yebei Li, et al.
Publicado: (2021)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss M, et al.
Publicado: (2017)

Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
por: Antonio Garcia-Gomez, et al.
Publicado: (2012)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
por: Tauber J, et al.
Publicado: (2018)

Exposure to an Extended-Interval, High-Dose Gentamicin Regimen in the Neonatal Period Is Not Associated With Long-Term Nephrotoxicity
por: Veronika Rypdal, et al.
Publicado: (2021)

Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
por: Huang Q, et al.
Publicado: (2016)

The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
por: Fu J, et al.
Publicado: (2016)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
por: Tauber J, et al.
Publicado: (2019)

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
por: Tauber J, et al.
Publicado: (2018)

Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats
por: Rachel Shvartsur, et al.
Publicado: (2021)

The Efficacy and Safety of Low Dose versus Usual Dose of Hyoscine During Endoscopic Retrograde Cholangiopancreatography: A Randomized Clinical Trial
por: Salmanroghani H, et al.
Publicado: (2020)

Innate T-αβ lymphocytes as new immunological components of anti-tumoral “off-target” effects of the tyrosine kinase inhibitor dasatinib
por: Alice Barbarin, et al.
Publicado: (2020)

Vitamin D levels do not cause vitamin-drug interactions with dexamethasone or dasatinib in mice.
por: Kavya Annu, et al.
Publicado: (2021)

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation
por: Chávez-Mondragón E, et al.
Publicado: (2019)

The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.
por: WorldWide Antimalarial Resistance Network (WWARN) DP Study Group
Publicado: (2013)

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor
por: Ophelia Yin, et al.
Publicado: (2021)

Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
por: Juliya V. Zhernakova, et al.
Publicado: (2021)

Comparison of the efficacy and safety of S-1-based and capecitabine-based regimens in gastrointestinal cancer: a meta-analysis.
por: Xunlei Zhang, et al.
Publicado: (2014)

Safety and feasibility of biventricular devices reuse in general and elderly population – a single-center retrospective cohort study
por: Şoşdean R, et al.
Publicado: (2015)

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
por: Filippo Massa, PhD, et al.
Publicado: (2021)

Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.
por: Dileep R Yavagal, et al.
Publicado: (2014)

A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance
por: Li J, et al.
Publicado: (2017)

Efficacy and safety of the application of extensive ablation in patients with atrioventricular re-entrant tachycardia (a retrospective study)
por: Guangze Xu, et al.
Publicado: (2021)

Low-Dose Exposure of Silica Nanoparticles Induces Neurotoxicity via Neuroactive Ligand–Receptor Interaction Signaling Pathway in Zebrafish Embryos
por: Wei J, et al.
Publicado: (2020)

Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity
por: Mariya B. Shapiro, et al.
Publicado: (2020)

Dose–Response Relationship Between BMI and Hyperuricemia
por: Yang L, et al.
Publicado: (2021)

Long-term efficacy and safety of bone cement-augmented pedicle screw fixation for stage III Kümmell disease
por: Guo-ye Mo, et al.
Publicado: (2021)

A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer
por: S. Mansoori, et al.
Publicado: (2021)